Lesinurad: what the nephrologist should know

Lesinurad is an oral inhibitor of the monocarboxylic/urate transporter URAT1 encoded by the SLC22A12 gene. Market authorization was granted in February 2016 in Europe and December 2015 in the USA. As a potentially nephrotoxic uricosuric drug acting on the kidney, nephrologists should become familiar...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Niño, Maria Dolores, Zheng-Lin, Binbin, Valiño-Rivas, Lara, Sanz, Ana Belen, Ramos, Adrian Mario, Luño, Jose, Goicoechea, Marian, Ortiz, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Cardiovascular Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622894/
https://www.ncbi.nlm.nih.gov/pubmed/28979780
http://dx.doi.org/10.1093/ckj/sfx036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622894/
https://www.ncbi.nlm.nih.gov/pubmed/28979780
http://dx.doi.org/10.1093/ckj/sfx036

Ejemplares similares